Scott D. Grimes - 22 Mar 2022 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role: Director
Signature: /s/ Kirk Somers, Attorney-in-Fact
Issuer symbol: CDLX
Transactions as of: 22 Mar 2022
Transactions value $: $0
Form type: 4
Filing time: 24 Mar 2022, 19:54:10
Previous filing: 21 Mar 2022
Next filing: 05 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDLX	Common Stock	Award	$0	+1.66K	+0.78%	$0.00	216K	24 Mar 2022	Direct	F1
holding	CDLX	Common Stock						53.1K	22 Mar 2022	See Footnote	F2
holding	CDLX	Common Stock						55.8K	22 Mar 2022	See Footnote	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDLX	Restricted Stock Unit	Award	$0	+31.2K	+228.47%	$0.00	44.8K	22 Mar 2022	Common Stock	31.2K		Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit ("RSU") award. The shares underlying the RSU award vested immediately upon grant.
F2	The reportable securities are held by the 2013 Scott Grimes GRAT UAD.
F3	The reportable securities are held by the UTMA Custodial account fbo Pierce Grimes.
F4	Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F5	25% of the RSUs shall vest on April 1, 2023 with the remainder vesting in equal amounts quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.